ITEM METADATA RECORD
Title: A pharmacoeconomic review of the management of respiratory tract infections with moxifloxacin
Authors: Simoens, Steven ×
Decramer, Marc #
Issue Date: Jul-2008
Publisher: Ashley Publications
Series Title: Expert Opinion on Pharmacotherapy vol:9 issue:10 pages:1735-44
Abstract: BACKGROUND: Moxifloxacin, a fluoroquinolone, has demonstrated its safety and effectiveness in the management of community-acquired pneumonia, acute exacerbations of chronic bronchitis and acute bacterial sinusitis. OBJECTIVE: The aim of this article was to provide a synthesis and critical appraisal of economic evaluations of the management of respiratory tract infections with moxifloxacin. METHODS: Studies were included if they assessed the costs and consequences of moxifloxacin as compared with an alternative antimicrobial in the management of community-acquired pneumonia, acute exacerbations of chronic bronchitis or acute bacterial sinusitis. RESULTS/CONCLUSIONS: Treatment of community-acquired pneumonia, acute exacerbations of chronic bronchitis or acute bacterial sinusitis with moxifloxacin is equally or more effective and less expensive than treatment with other antimicrobials.
URI: 
ISSN: 1465-6566
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Pneumology
Research Centre for Pharmaceutical Care and Pharmaco-economics (-)
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy

 




All items in Lirias are protected by copyright, with all rights reserved.

© Web of science